Biotech growth stock TG Therapeutics (TGTX) got FDA approval for its multiple sclerosis drug in December, setting off a strong advance that’s added 80% so far this year. You can find these outst...
Tag: sclerosis
Now That FDA Approved TG Therapeutics Multiple Sclerosis Treatment, Analyst Are Boosting Price Targets
Wednesday, the FDA approved TG Therapeutics Inc’s (NASDAQ: TGTX) Briumvi (ublituximab-xiiy) for relapsing forms of multiple sclerosis (RMS). Briumvi is the first and only anti-CD20 monoclonal an...
It’s Time To Cure The FDA’s Regulatory Sclerosis
WHITE OAK, MD – JULY 20: A sign for the Food And Drug Administration is seen outside of the … [+] headquarters on July 20, 2020 in White Oak, Maryland. (Photo by Sarah Silbiger/Getty Image...